(Q39294614)

10 September 2017

title

Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system (English)

1 reference

10 September 2017

1 reference

Elke Theander

1

1 reference

10 September 2017

Thomas Mandl

series ordinal

2

1 reference

10 September 2017

publication date

1 July 2014

1 reference

Arthritis Care and Research

10 September 2017

published in

1 reference

10 September 2017

volume

66

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

1102-1107

1 reference

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

10 September 2017

cites work

1 reference

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort

21 January 2018

1 reference

Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue

21 January 2018

1 reference

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

21 January 2018

1 reference

Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria?

21 January 2018

1 reference

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

21 January 2018

1 reference

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

21 January 2018

1 reference

Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome

21 January 2018

1 reference

Urban legends series: Sjögren's syndrome

21 January 2018

1 reference

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial

21 January 2018

1 reference

Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ACR.22264

1 reference

10 September 2017

1 reference